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Diffuse dermal angiomatosis (DDA) is a type of reactive 
skin angioproliferation. Clinically, this rare disorder 
presents as red-violet purpuric papules and/or plaques 
(some with a greater tendency towards necrosis and 
ulceration), which can be localized in any body area, 
but is most often seen in the upper and lower extremi-
ties. Histological examination is fundamental for the 
diagnosis, and is characterized by varied patterns of 
lobular or diffuse hyperplasia of endothelial cells at the 
extravascular level. We describe here a case of DDA in 
a 42-year-old man with an arterio-venous fistula and 
Wegener’s granulomatosis.
CASE REPORT
A 42-year-old man presented to our clinic due to a 2-year history 
of non-painful, hard, reddish-purple plaques and nodules on the 
right arm nearby a haemodialysis-related arterio-venous fistula 
(Fig. 1a). During this time period, the lesions had increased 
slightly in number and volume without signs of regression. 
Ten years previously, the patient had pulmonary and renal ma-
nifestations compatible with Wegener’s granulomatosis. This 
clinical diagnosis was confirmed upon biopsy of both the lungs 
and the kidneys, which showed granulomas and vasculitis. He 
was treated with mycophenolate mofetil, methylprednisolone, 
and ticlopidine prior to our observation. Cutaneous signs of 
Wegener’s granulomatosis, such as necrotizing, granulomatous 
vasculitis, were not visible at clinical presentation. Complete 
blood count with differential and a complete metabolic pa-
nel denoted high fibrinogen, creatinine, C-reactive protein, 
anti-neutrophil cytoplasmic antibody, white blood cell, and 
neutrophil levels, and a low haemoglobin level. Prothrombin, 
activated partial prothromboplatin time, and D-dimer levels 
were unremarkable. Histological examination performed on 
a purpuric lesion showed diffuse capillary proliferation in the 
superficial and deep dermis (Fig.1b). A few vascular structu-
res were dilated by erythrocytes and contained a prominent 
endothelium. Immunohistochemistry showed positive CD31 
staining, confirming the presence of endothelial cells in the 
dermal infiltrate (Fig.1c) and negativity for HHV-8. 
DISCUSSION
The clinical presentation of our patient suggested 3 cu-
taneous reactive angiomatoses, which can resemble one 
another and can occur in association with an arteriove-
nous fistula: DDA, reactive angioendotheliomatosis, or 
acroangio dermatitis (pseudo-Kaposi’s sarcoma). A distin-
ction is made between them on histological examination 
(3, 4). Both histological and immunohistochemistry 
suggested DDA, a reactive, dermal, vascular lesion with 
a distinct pattern (3). While DDA demonstrates diffuse 
endothelial extravascular hyperplasia in the superficial 
and deep dermis between collagen bundles, reactive 
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Fig. 1. (a) Reddish-purple plaques and nodules 
localized on the right arm close to an arterio-venous 
fistula. (b) Histopathological examination shows a 
diffuse proliferation of capillary vascular structures in 
the superficial and deep dermis (haematoxylin-eosin 
stain; magnification × 20). (c) CD31 stains a prominent 
endothelium decorating the vascular structures of 
variable size and shape in an interstitial pattern among 
collagen bundles (magnification × 20).
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angioendotheliomatosis is characterized by endothelial 
proliferation within the lumen of dermal vessels. Pseudo-
Kaposi’s sarcoma, by contrast, exhibits a slight endothe-
lial proliferation and formation of new thick-walled 
vessels, often in a lobular arrangement in the papillary 
dermis. Kaposi’s sarcoma (HHV-8+) might also be con-
sidered in the differential diagnosis, as this condition is 
characterized by red-violet patches, plaques or nodules, 
located mainly on the extremities; its histological profile 
consists of spindle cells and vascular structures with a 
characteristic clefting pattern (vascular slits). However, 
intravascular proliferation, as seen in DDA, is not present 
in pseudo-Kaposi’s sarcoma.
According to current literature, cutaneous reactive 
angiomatoses, such as DDA, might be attributed to 
occlusive or inflammatory vasculopathic processes in 
the vascular tree, which result in the formation of mi-
crothrombi and subsequent hypoxia (3). Subsequently, 
histiocytes are recruited and hyperplasia of endothelial 
cells and pericytes occurs. The former plays a role in 
the reabsorption of microthrombi. We hypothesize that 
both arteriovenous fistula and the patient’s concomitant 
Wegener’s granulomatosis resulted in ischaemia. This 
phenomenon induces vascular endothelial growth factor 
(VEGF), which in turn stimulates endothelial extravas-
cular hyperplasia, as seen in DDA (3).
While no definitive therapeutic protocols exist for 
cutaneous reactive angiomatoses, systemic or topical 
corticosteroids are used for their anti-angiogenetic pro-
perties. The results are not always effective (1, 3). Use 
of systemic corticosteroids for an underlying Wegener’s 
granulomatosis did not prevent a progressive diffusion 
of DDA over the entire forearm of our patient. The topi-
cal corticosteroid, 0.1% methylprednisolone aceponate, 
was utilized in our patient without improvement at a 
1-year follow-up. It is possible, however, that these 
lesions spontaneously improve or disappear.
DDA is a very rare manifestation, according to the 
current literature, which can appear secondary to an 
arteriovenous fistula in patients with chronic renal in-
sufficiency who undergo haemodialysis. To our know-
ledge, the present case is only the third reported (1, 2). 
Sommer et al. (2) describe the concomitant presence of 
Wegener’s granulomatosis as in our patient, suggesting 
that DDA is favoured by systemic diseases involving 
occlusive or inflammatory vasculopathy.
ACKNOWLEDGEMENT
The authors thank Professor Daniela Massi, MD, for assisting 
with the histopathological assessment.
The authors declare no conflicts of interest.
REFERENCES
1. Requena L, Fariña MC, Renedo G, Alvarez A, Yus ES, 
Sangueza OP. Intravascular and diffuse dermal reactive 
angioendotheliomatosis secondary to iatrogenic arteriove-
nous fistulas. J Cutan Pathol 1999; 26: 159–164.
2. Sommer S, Merchant WJ, Wilson CL. Diffuse dermal angi-
omatosis due to an iatrogenic arteriovenous fistulas. Acta 
Derm Venereol 2004; 84: 251–252.
3. Rongioletti F, Rebora A. Cutaneous reactive angiomatoses: 
patterns and classification of reactive vascular proliferation. 
J Am Acad Dermatol 2003; 49: 887–896.
4. Lazova R, Slater C, Scott G. Reactive angioendothe-
liomatosis: case report and review of the literature. Am J 
Dermatopathol 1996; 18: 63–69.
Acta Derm Venereol 93
